FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16590911000001104: Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Feb 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
58045701000001115 Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58208501000001117 Wellvone 750mg/5ml oral suspension (GlaxoSmithKline UK Ltd) 226 ml en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Is a Atovaquone 750mg/5ml oral suspension sugar free 226 ml true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has AMP Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has excipient Benzyl alcohol false Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has specific active ingredient Atovaquone true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Wellvone 750mg/5ml oral suspension (GlaxoSmithKline) 226 ml Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start